What is good for the circulation also lessens cancer risk

Eur Heart J. 2015 May 14;36(19):1157-62. doi: 10.1093/eurheartj/ehu457. Epub 2015 Mar 15.

Authors

Lionel H Opie¹, Gary D Lopaschuk²

Affiliations

¹ Department of Medicine, Groote Schuur Hospital and Hatter Institute for Cardiovascular Research in Africa, Observatory, Cape Town, South Africa lionel.opie@uct.ac.za.
² Cardiovascular Research Centre, University of Alberta, Edmonton, Alberta, Canada.

PMID: 25776859
DOI: 10.1093/eurheartj/ehu457

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Anticarcinogenic Agents / pharmacology
Anticarcinogenic Agents / therapeutic use
Aspirin / pharmacology
Aspirin / therapeutic use
Cardiovascular Diseases / complications
Cardiovascular Diseases / mortality
Cardiovascular Diseases / prevention & control*
Epidemiologic Methods
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Neoplasms / complications
Neoplasms / mortality
Neoplasms / prevention & control*
Risk Factors
Risk Reduction Behavior

Substances

Anticarcinogenic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Aspirin